Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-02

Clinical Trial Update: A Study of Balapiravir in Patients With Dengue Virus Infection [Phase 1]

View source ↗

Summary

Phase 1 study of balapiravir in patients with dengue virus infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Balapiravir (balapiravir)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Dengue | Phase 1 | Status: COMPLETED